Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
Veeva Systems Inc. logo

NYSE · VEEV

Veeva Systems Inc.

Healthcare · Medical - Healthcare Information Services

$312.96

Up+$2.62 (+0.84%)

Updated Oct 31, 2026, 5:24 PM

SID Score

6.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
37.72B
P/E ratio
43.66
Dividend yield
0.00%
52-week range
$148.05 – $325.99
Volume
1.38M
Avg. volume
1.54M

Price performance · VEEV

VEEV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

VEEV closed at $312.96 after 21 trading sessions, up 14.50% for the selected period.

Last close
$312.96
Period change
+14.50%
Period low
$273.33
Period high
$323.04
Daily close
View OHLC price history
VEEV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$312.06$314.4999$309.42$312.961.38M
Oct 29, 2026$312.11$315.235$306.50$310.341.79M
Oct 28, 2026$310.00$319.00$308.50$317.821.4M
Oct 27, 2026$315.50$318.51$310.50$313.461.36M
Oct 26, 2026$323.04$325.87$316.91$318.181.12M
Oct 23, 2026$320.67$324.76$319.00$323.041.37M
Oct 22, 2026$323.99$325.99$318.03$322.551.44M
Oct 21, 2026$317.01$322.99$316.075$320.551.43M
Oct 20, 2026$318.00$322.00$310.38$318.671.81M
Oct 19, 2026$310.33$318.28$310.33$316.801.38M
Oct 16, 2026$319.95$319.95$306.575$310.361.73M
Oct 15, 2026$295.67$315.02$295.67$313.032.87M
Oct 14, 2026$300.14$301.50$293.66$297.351.24M
Oct 13, 2026$300.00$309.3195$299.895$301.632.25M
Oct 12, 2026$296.53$300.63$293.665$295.851.14M
Oct 9, 2026$285.71$297.45$284.00$296.131.85M
Oct 8, 2026$282.13$285.245$279.0201$284.84922.1K
Oct 7, 2026$284.23$286.98$279.795$282.501.12M
Oct 6, 2026$285.34$289.87$282.2628$283.501.17M
Oct 5, 2026$275.00$283.47$274.00$283.451.32M
Oct 2, 2026$283.10$284.59$272.835$273.331.08M

Latest VEEV news

The latest Smart Investors Daily articles mentioning VEEV.

Stock researchCompany · Overview

VEEV research

Overview

Company profile and research snapshot.

Company profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$313.67
Implied upside
—
Analysts
40
VEEV recent ratings
DateFirmRatingTarget
Oct 28, 2026BarclaysOverweight—
Oct 26, 2026BairdOutperform—
Oct 19, 2026BarclaysOverweight—
Aug 28, 2026CitigroupNeutral—
Aug 27, 2026UBSNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 22, 2026

Global Decentralized Clinical Trials Market Size, Share, Growth Trends, and Forecast 2026-2035 | Clinical Trials leave the Clinic as the Decentralized Model Heads for a $28.4bn Market

New Report values decentralised clinical trials at $8bn in 2025, with hybrid models taking 54.1% and North America 44.2%, though data integrity and patchy regulation across regions still trouble IQVIA, Medidata, Medable and Veeva SystemsDublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Decentralized Clinical Trials Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. The Global Decentralized Clinical Trials Market was

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By